πŸ‡ΊπŸ‡Έ FDA
Patent

US 8598121

Variants of C-type natriuretic peptide

granted A61KA61K38/00A61K38/22

Quick answer

US patent 8598121 (Variants of C-type natriuretic peptide) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61K38/22, A61K38/2242, A61K47/10